TM Capital. Success. Realized. | Immucor Acquires Gamma Biologicals

Immucor, Inc. (NASDAQ: BLUD) is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions
Immucor retained TM Capital as financial advisor to assist in an acquisition program which would build the company’s position in the transfusion diagnostics marketplace
TM Capital assisted Immucor in negotiating the acquisition of Gamma Biologicals, Inc. (AMEX: GBL) for $30 million via a cash tender offer for which TM Capital also served as dealer manager

has acquired through a cash tender offer

TM Capital assisted Immucor, Inc. (NASDAQ) in completing the $30 million acquisition of Gamma Biologicals, Inc. (AMEX) via a cash tender offer

For more information, contact our healthcare team at:

”

Immucor Acquires Gamma Biologicals